Published December 2, 2016 | Version v1
Journal article

The transcription factor Prep1 controls hepatic insulin sensitivity and gluconeogenesis by targeting nuclear localization of FOXO1

  • 1. Lomonosov Moscow State University, Faculty of Fundamental Medicine, Department of Biochemistry and Molecular Medicine, Lomonosovsky Prospekt 31-5, Moscow, 117192 (Russian Federation)
  • 2. IFOM – the FIRC Institute of Molecular Oncology, Via Adamello 16, Milan, 20139 (Italy)

Description

Liver plays a key role in controlling body carbohydrate homeostasis by switching between accumulation and production of glucose and this way maintaining constant level of glucose in blood. Increased blood glucose level triggers release of insulin from pancreatic β-cells. Insulin represses hepatic glucose production and increases glucose accumulation. Insulin resistance is the main cause of type 2 diabetes and hyperglycemia. Currently thiazolidinediones (TZDs) targeting transcriptional factor PPARγ are used as insulin sensitizers for treating patients with type 2 diabetes. However, TZDs are reported to be associated with cardiovascular and liver problems and stimulate obesity. Thus, it is necessary to search new approaches to improve insulin sensitivity. A promising candidate is transcriptional factor Prep1, as it was shown earlier it could affect insulin sensitivity in variety of insulin-sensitive tissues. The aim of the present study was to evaluate a possible involvement of transcriptional factor Prep1 in control of hepatic glucose accumulation and production. We created mice with liver-specific Prep1 knockout and discovered that hepatocytes derived from these mice are much more sensitive to insulin, comparing to their WT littermates. Incubation of these cells with 100 nM insulin results in almost complete inhibition of gluconeogenesis, while in WT cells this repression is only partial. However, Prep1 doesn't affect gluconeogenesis in the absence of insulin. Also, we observed that nuclear content of gluconeogenic transcription factor FOXO1 was greatly reduced in Prep1 knockout hepatocytes. These findings suggest that Prep1 may control hepatic insulin sensitivity by targeting FOXO1 nuclear stability. - Highlights: • A novel model of liver-specific Prep1 knockout is established. • Ablation of Prep1 in hepatocytes increases insulin sensitivity. • Prep1 controls hepatic insulin sensitivity by regulating localization of FOXO1. • Prep1 regulates localization of FOXO1 via Wnt/β-catenin signaling pathway.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2016.10.146

Additional details

Identifiers

DOI
10.1016/j.bbrc.2016.10.146;
PII
S0006-291X(16)31841-1;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
481
Journal Issue
1-2
Journal Page Range
p. 182-188
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
49046413
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
GLUCOSE; INSULIN; KNOCK-OUT REACTIONS; LIVER CELLS; METABOLIC DISEASES; PRODUCTIVITY; SENSITIVITY; TRANSCRIPTION FACTORS
Descriptors DEC
ALDEHYDES; ANIMAL CELLS; CARBOHYDRATES; DIRECT REACTIONS; DISEASES; HEXOSES; HORMONES; MONOSACCHARIDES; NUCLEAR REACTIONS; ORGANIC COMPOUNDS; PEPTIDE HORMONES; PROTEINS; SACCHARIDES; SOMATIC CELLS

Optional Information

Copyright
Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.